Blue Owl Capital Corporation is a Private Debt, business development company That specializes in direct and fund of fund investments. The fund makes investments in senior secured, direct lending or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments, first lien, unitranche, and second lien term loans and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market and upper middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2500 million at the time of investment. It seeks to invest in investments with maturities typically between three and ten years. It seeks to make investments generally ranging in size between $20 million and $250 million.…
$100,000 in These 2 Dividend Stocks Could Pay Over $10,000 a Year
Blue Owl Capital (NYSE: OBDC) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Asset Management industry, part of the Financial Services sector.
The shares were at 10.60 USD on 20 November 2026, down 4.7% over 52 weeks. Its 52-week range is 9.813 USD to 13.57 USD: the price is 21.9% below the high and 8.0% above the low.
At a market capitalisation of 5.19B USD, it trades at 15.6 times trailing earnings and 7.8 times forward earnings. The median trailing P/E of its 18 largest Asset Management peers is 14.8, so OBDC is valued in line with them. It pays a dividend yielding 12.52% (it pays out 157% of its earnings), against a median of 1.81% among the dividend payers in that peer group.
Blue Owl Capital reports return on equity of 8.5%, an operating margin of 75.1% and revenue down 13.5% year over year.
Its debt exceeds its cash by 7.83B USD, a debt-to-equity ratio of 1.26. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 13 analysts cover the stock, with an average rating of Buy; their mean price target of 13.02 USD is 22.8% above the current price. The next earnings report is expected on 17 February 2027.